Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs
Antoine Rebendenne, Priyanka Roy, Boris Bonaventure, et al.
Nature Genetics (2022) Vol. 54, Iss. 8, pp. 1090-1102
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

SARS-CoV-2 biology and host interactions
Silvio Steiner, Annika Kratzel, G. Tuba Barut, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 4, pp. 206-225
Closed Access | Times Cited: 81
Porcine Epidemic Diarrhea Virus: An Updated Overview of Virus Epidemiology, Virulence Variation Patterns and Virus–Host Interactions
Yuan‐Zhu Zhang, Yiwu Chen, Jian Zhou, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2434-2434
Open Access | Times Cited: 74
Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection
Jiakai Hou, Yanjun Wei, Jing Zou, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly
Émilie Murigneux, Laurent Softic, C. Aubé, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling
Scott B. Biering, Francielle Tramontini Gomes de Sousa, Laurentia V. Tjang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor
Oded Danziger, Roosheel S. Patel, Emma J. DeGrace, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 4, pp. e1010464-e1010464
Open Access | Times Cited: 47
Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection
Jin Wei, Ajinkya Patil, Clayton K. Collings, et al.
Nature Genetics (2023) Vol. 55, Iss. 3, pp. 471-483
Open Access | Times Cited: 33
Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs
Lipin Loo, Matthew A. Waller, Cesar L. Moreno, et al.
PLoS Biology (2023) Vol. 21, Iss. 2, pp. e3001967-e3001967
Open Access | Times Cited: 24
A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus
Longping V. Tse, Yixuan J. Hou, Elizabeth McFadden, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 715
Open Access | Times Cited: 24
Membrane remodeling and trafficking piloted by SARS-CoV-2
Maria Concetta Sergio, Simona Ricciardi, Andrea Maria Guarino, et al.
Trends in Cell Biology (2024) Vol. 34, Iss. 9, pp. 785-800
Open Access | Times Cited: 12
Chromatin remodellers as therapeutic targets
Hayden A. Malone, Charles W.M. Roberts
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 661-681
Closed Access | Times Cited: 11
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38
Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2
Ma’ayan Israeli, Yaara Finkel, Yfat Yahalom-Ronen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Molecular Virology of SARS-CoV-2 and Related Coronaviruses
Yu-An Kung, Kuo-Ming Lee, Huan-Jung Chiang, et al.
Microbiology and Molecular Biology Reviews (2022) Vol. 86, Iss. 2
Open Access | Times Cited: 34
Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection
Taif Shah, Zahir Shah, Nafeesa Yasmeen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis
Hu Meng, Arjun Sengupta, Emanuela Ricciotti, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 11
Open Access | Times Cited: 19
Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq
Sara Sunshine, Andreas S. Puschnik, Joseph M. Replogle, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
ER-export and ARFRP1/AP-1–dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication
Guy Pearson, Harriet V Mears, Malgorzata Broncel, et al.
Science Advances (2024) Vol. 10, Iss. 14
Open Access | Times Cited: 8
Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection
Jessica M. Vanslambrouck, Jessica A. Neil, Rajeev Rudraraju, et al.
Journal of Virology (2024) Vol. 98, Iss. 3
Open Access | Times Cited: 7
The antiviral state of the cell: lessons from SARS-CoV-2
Jérémie Le Pen, Charles M. Rice
Current Opinion in Immunology (2024) Vol. 87, pp. 102426-102426
Closed Access | Times Cited: 7
Genome-wide CRISPR activation screen identifies JADE3 as an antiviral activator of NF-kB–dependent IFITM3 expression
Moiz Munir, Aaron Embry, John G. Doench, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 4, pp. 107153-107153
Open Access | Times Cited: 6
Deep profiling of potential substrate atlas of porcine epidemic diarrhea virus 3C-like protease
Junwei Zhou, Peng Sun, Yuanqing Wang, et al.
Journal of Virology (2024) Vol. 98, Iss. 5
Closed Access | Times Cited: 6
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist
Jérémie Le Pen, Gabrielle Paniccia, Volker Kinast, et al.
PLoS Biology (2024) Vol. 22, Iss. 9, pp. e3002767-e3002767
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top